Recent MSK Discoveries & Advances

Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
373 News Items found
MSK physician-scientist Vinod Balachandran.
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
In the Clinic
MSK radiation oncologist Nancy Lee
Low-Dose Radiation To Treat HPV Throat Cancer a ‘Game Changer’

Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects.
In the Clinic
MSK radiation oncologist and neuroblastoma expert Suzanne Wolden with a patient
Reduced Radiation for Neuroblastoma Could Lessen Children’s Side Effects Later

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.
Feature
MSK melanoma expert James Smithy, MD
New Treatments Improving Prognosis for Stage 4 Melanoma Patients

In recent years, advanced melanoma (a type of skin cancer) has been transformed from a disease that was almost always fatal to one that often can be br...
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously

Learn how a blood test could someday provide a way to detect cancers at an early stage.
Medical oncologist Saad Usmani, who specializes in treating multiple myeloma.
Multiple Myeloma: Improved Prognosis With the Latest Treatments

Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.
Postdocs Francisco “Pancho” Barriga and Kaloyan Tsanov in the lab
New MACHETE Technique Slices Into Cancer Genome To Study Copy Number Alterations

Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
Feature
Medical oncologist and male breast cancer expert Ayca Gucalp
What You Need To Know About Male Breast Cancer

MSK experts discuss risk factors, symptoms, and treatment for male breast cancer.
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
Side-by-side headshots of scientists Christopher Lima and Rhyan Puno
With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.